Simulations Plus (SLP)

• Market cap: $295M
• 1 day: -2.46%
• 5 days: 4.48%
• 1 month: 3.09%
• 3 months: -22.53%
• 6 months: -44.03%
• Year to date: -47.4%
• 1 year: -54.2%
• 5 years: -77.79%
• 10 years: 79.24%
• Sector: Healthcare
• Industry: Health Information Services

About: Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Employees: 247

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

41% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 44

0.55% more ownership

Funds ownership: 84.02% [Q1] → 84.57% (+0.55%) [Q2]

4% less funds holding

Funds holding: 162 [Q1] → 156 (-6) [Q2]

15% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 26

28% less capital invested

Capital invested by funds: $414M [Q1] → $297M (-$117M) [Q2]

98% less call options, than puts

Call options by funds: $14K | Put options by funds: $690K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $20
• Avg. target: $23
• High target: $25

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Stephens & Co. Jeff Garro	$20	Overweight Maintained	15 Jul 2025
BTIG David Larsen	$25	Buy Maintained	7 Jul 2025